Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe.

Jung A, Orenti A, Dunlevy F, Aleksejeva E, Bakkeheim E, Bobrovnichy V, Carr SB, Colombo C, Corvol H, Cosgriff R, Daneau G, Dogru D, Drevinek P, Vukic AD, Fajac I, Fox A, Fustik S, Gulmans V, Harutyunyan S, Hatziagorou E, Kasmi I, Kayserová H, Kondratyeva E, Krivec U, Makukh H, Malakauskas K, McKone EF, Mei-Zahav M, de Monestrol I, Olesen HV, Padoan R, Parulava T, Pastor-Vivero MD, Pereira L, Petrova G, Pfleger A, Pop L, van Rens JG, Rodic M, Schlesser M, Storms V, Turcu O, Woz Niacki L, Yiallouros P, Zolin A, Downey DG, Naehrlich L

Open source

DOI
10.1183/23120541.00411-2021
Published
2021 Oct
Container
ERJ open research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1183/23120541.00411-2021,
  title = {Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe.},
  author = {Jung A and Orenti A and Dunlevy F and Aleksejeva E and Bakkeheim E and Bobrovnichy V and Carr SB and Colombo C and Corvol H and Cosgriff R and Daneau G and Dogru D and Drevinek P and Vukic AD and Fajac I and Fox A and Fustik S and Gulmans V and Harutyunyan S and Hatziagorou E and Kasmi I and Kayserová H and Kondratyeva E and Krivec U and Makukh H and Malakauskas K and McKone EF and Mei-Zahav M and de Monestrol I and Olesen HV and Padoan R and Parulava T and Pastor-Vivero MD and Pereira L and Petrova G and Pfleger A and Pop L and van Rens JG and Rodic M and Schlesser M and Storms V and Turcu O and Woz Niacki L and Yiallouros P and Zolin A and Downey DG and Naehrlich L},
  year = {2021},
  journal = {ERJ open research},
  doi = {10.1183/23120541.00411-2021},
  url = {https://doi.org/10.1183/23120541.00411-2021}
}

RIS

TY  - JOUR
TI  - Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe.
AU  - Jung A
AU  - Orenti A
AU  - Dunlevy F
AU  - Aleksejeva E
AU  - Bakkeheim E
AU  - Bobrovnichy V
AU  - Carr SB
AU  - Colombo C
AU  - Corvol H
AU  - Cosgriff R
AU  - Daneau G
AU  - Dogru D
AU  - Drevinek P
AU  - Vukic AD
AU  - Fajac I
AU  - Fox A
AU  - Fustik S
AU  - Gulmans V
AU  - Harutyunyan S
AU  - Hatziagorou E
AU  - Kasmi I
AU  - Kayserová H
AU  - Kondratyeva E
AU  - Krivec U
AU  - Makukh H
AU  - Malakauskas K
AU  - McKone EF
AU  - Mei-Zahav M
AU  - de Monestrol I
AU  - Olesen HV
AU  - Padoan R
AU  - Parulava T
AU  - Pastor-Vivero MD
AU  - Pereira L
AU  - Petrova G
AU  - Pfleger A
AU  - Pop L
AU  - van Rens JG
AU  - Rodic M
AU  - Schlesser M
AU  - Storms V
AU  - Turcu O
AU  - Woz Niacki L
AU  - Yiallouros P
AU  - Zolin A
AU  - Downey DG
AU  - Naehrlich L
PY  - 2021
JO  - ERJ open research
DO  - 10.1183/23120541.00411-2021
UR  - https://doi.org/10.1183/23120541.00411-2021
ER  -

APA

A, J., A, O., F, D., E, A., E, B., V, B., SB, C., C, C., H, C., R, C., G, D., D, D., P, D., AD, V., I, F., A, F., S, F., V, G., S, H., E, H., I, K., H, K., E, K., U, K., H, M., K, M., EF, M., M, M., I, D. M., HV, O., R, P., T, P., MD, P., L, P., G, P., A, P., L, P., JG, V. R., M, R., M, S., V, S., O, T., L, W. N., P, Y., A, Z., DG, D., & L, N. (2021). Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe.. ERJ open research. https://doi.org/10.1183/23120541.00411-2021

Source records